Koppel Adam

CIK 000157896516 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001578965

Recent Transactions

50 trades

Conversion
Kailera Therapeutics, Inc.$KLRA
Common Stock
2026-04-20+16,875,000→ 16,875,000 total
Conversion
Kailera Therapeutics, Inc.$KLRA
Common Stock
2026-04-20+4,145,768→ 21,020,768 total
Conversion
Kailera Therapeutics, Inc.$KLRA
Series B Preferred Stock
2026-04-20−4,145,768→ 0 total
Conversion
Kailera Therapeutics, Inc.$KLRA
Series A-1 Preferred Stock
2026-04-20−16,875,000→ 0 total
Purchase
Kailera Therapeutics, Inc.$KLRA
Common Stock
2026-04-20$16.00/sh+1,562,500→ 22,583,268 total
Award
Kailera Therapeutics, Inc.$KLRA
Stock Option (right to buy)
2026-04-16+38,300→ 38,300 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−65,679,781→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2024-08-01−80,189→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−10,461→ 0 total
Disposition to Issuer
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-08-01−3,282→ 10,461 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2024-06-26$5.52/sh+16,000→ 16,000 total
Award
Cerevel Therapeutics Holdings, Inc.
Common Stock
2024-06-05+10,461→ 13,743 total
Award
Solid Biosciences Inc.$SLDB
Common Stock
2024-01-11$5.53/sh+904,160→ 4,034,582 total
Purchase
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-10-16$22.81/sh+5,480,052→ 65,679,781 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2023-06-21+16,000→ 16,000 total
Award
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-06-07+3,282→ 3,282 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2023-06-07+13,780→ 13,780 total
Other
Cerevel Therapeutics Holdings, Inc.
Common Stock
2023-06-07−432,627→ 60,199,729 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2023-06-06+9,650→ 9,650 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2022-12-13+9,650→ 9,650 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right to Buy)
2022-12-02+2,666→ 2,666 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Options (Right to buy)
2022-06-21+16,000→ 16,000 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2022-06-14+23,459→ 23,459 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2022-05-26+40,000→ 40,000 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−25,000→ 0 total
Disposition from Tender
Dicerna Pharmaceuticals Inc
Common Stock
2021-12-28$38.25/sh−3,080,237→ 0 total
Disposition from Tender
Dicerna Pharmaceuticals Inc
Common Stock
2021-12-28$38.25/sh−3,333→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−25,000→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Restricted Stock Units
2021-12-28−3,333→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−15,000→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−25,000→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−15,000→ 0 total
Disposition to Issuer
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-12-28−25,000→ 0 total
Award
Foghorn Therapeutics Inc.$FHTX
Stock Option (right to buy)
2021-07-13+12,530→ 12,530 total
Award
Solid Biosciences Inc.$SLDB
Director Stock Option (Right To Buy)
2021-06-16+30,000→ 30,000 total
Award
Cerevel Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
2021-06-10+42,950→ 42,950 total
Exercise/Conversion
Dicerna Pharmaceuticals Inc
Common Stock
2021-06-03+3,333→ 3,333 total
Award
Dicerna Pharmaceuticals Inc
Director Stock Option (Right to Buy)
2021-06-03+15,000→ 15,000 total
Award
Dicerna Pharmaceuticals Inc
Restricted Stock Units
2021-06-03+3,333→ 3,333 total
Exercise/Conversion
Dicerna Pharmaceuticals Inc
Restricted Stock Units
2021-06-03−3,333→ 0 total
Award
Aptinyx Inc.
Stock Option(Right Buy)
2021-05-27+40,000→ 40,000 total
Award
Solid Biosciences Inc.$SLDB
Common Stock
2021-03-23$5.75/sh+869,565→ 7,929,918 total
Award
Aptinyx Inc.
Stock Option (Right Buy)
2020-12-31$2.22/sh+5,508→ 5,508 total
Sale
Dicerna Pharmaceuticals Inc
Common Stock
2020-12-10$23.40/sh−1,000,000→ 3,080,237 total
Award
Solid Biosciences Inc.$SLDB
Common Stock
2020-12-10$3.70/sh+3,189,189→ 7,060,353 total
Purchase
Cerevel Therapeutics Holdings, Inc.
Common Stock
2020-11-09$10.30/sh+332,293→ 60,632,356 total
Other
Cerevel Therapeutics Holdings, Inc.
Common Stock
2020-10-27+49,961,943→ 50,300,063 total
Purchase
Cerevel Therapeutics Holdings, Inc.
Common Stock
2020-10-27$10.00/sh+10,000,000→ 60,300,063 total
Award
BCLS Acquisition Corp.
Class A ordinary shares
2020-10-26$10.00/sh+487,500→ 487,500 total
Award
Aptinyx Inc.
Stock Option (Right to Buy)
2020-09-30$2.16/sh+5,663→ 5,663 total

Companies

Recent Filings

Address

C/O BAIN CAPITAL LIFE SCIENCES INVESTORS LLC 200 CLARENDON STREET

BOSTON, MA, 02116

View on SEC.gov